ARTICLE
|
doi:10.20944/preprints202206.0272.v1
Subject:
Medicine And Pharmacology,
Pulmonary And Respiratory Medicine
Keywords:
COVID-19; SARS-CoV-2; molnupiravir; nirmatrelvir; GC376; PF-07321332; variant; synergy; an-tiviral
Online: 20 June 2022 (10:57:26 CEST)